Raymond James Defending Sionna Therapeutics (SION) Amid 7% Selloff

May 12, 2026 9:47 AM EDT Send to a Friend
Raymond James analyst Chris Raymond reiterated a Strong Buy rating and $53.00 price target on Sionna Therapeutics (NASDAQ: SION).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login